Carglumic Acid Market 2035: Future Growth, Innovation, and Industry Outlook
The Carglumic Acid Market is expected to witness steady growth through 2035, driven by advances in genetic testing, newborn screening, and rare disease diagnosis. Increasing awareness of urea cycle disorders (UCDs) and N-acetylglutamate synthase (NAGS) deficiency, along with growing investments in orphan drug development, is supporting market expansion. Ongoing innovation in treatment approaches, improved patient access to specialist care, and stronger global rare disease networks are expected to create new opportunities, positioning the carglumic acid market for sustainable long-term growth.